1,2-distearoyllecithin has been researched along with amphotericin b in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolard, J; Carbon, C; Joly, V; Saint-Julien, L; Yeni, P | 1 |
| Adler-Moore, JP; Chiang, SM; Proffitt, RT; Satorius, A; Sullivan, L | 1 |
2 other study(ies) available for 1,2-distearoyllecithin and amphotericin b
| Article | Year |
|---|---|
Influence of phospholipid/amphotericin B ratio and phospholipid type on in vitro renal cell toxicities and fungicidal activities of lipid-associated amphotericin B formulations.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Circular Dichroism; Dimyristoylphosphatidylcholine; Drug Carriers; Kidney; Kidney Tubules; Male; Membranes, Artificial; Phosphatidylcholines; Phospholipids; Rabbits | 1992 |
Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents.
Topics: Amphotericin B; Animals; Cholesterol; Drug Carriers; Female; Freeze Drying; Lethal Dose 50; Liposomes; Mice; Mice, Inbred C57BL; Phosphatidylcholines; Rats; Rats, Inbred Strains | 1991 |